Publizoom

Call for tenders Supplies

Bévacizumab

Notice published in French. The AI analysis summarises it for you in your language.

Tenders due closed — 16 February 2026 at 14:10

Public buyer
Cliniques universitaires Saint Luc
Woluwe-Saint-Lambert
Place of performance
1200 Woluwe-Saint-Lambert, Brussels-Capital
not published: buyer's address
Form
Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure
Open procedure
Any company may submit a bid.
Publication
19 December 2025
Notice language
French

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Le marché concerne les fournitures de la spécialité pharmaceutique contenant le principe actif « Bévacizumab » pour injection en flacons « ready to use » de 100mg et 400mg.

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33650000

Winning prices for comparable contracts

A quarter below
€290,000
Median
€403,000
A quarter above
€1,351,075

Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Likely competitors: who wins with this buyer in this field

Partners and subcontractors

Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.

Create your free account to see who is looking for a partner on this contract, and to register.

Companies winning this type of contract in the region

Possible partners for a temporary consortium or subcontracting… and competitors worth knowing.

Similar contracts already awarded

ContractWinnerAmount
Immunoglobuline humaine normale pour administration intraveineuse
Cliniques universitaires Saint Luc · 22 October 2026
CSL BEHRING €16,277,080
Rituximab
Cliniques universitaires Saint Luc · 19 August 2026
Celltrion Healthcare Netherlands B.V. €628,800
Infliximab
Cliniques universitaires Saint Luc · 19 August 2026
Celltrion Healthcare Netherlands B.V. €2,492,000
Bévacizumab
Cliniques universitaires Saint Luc · 7 July 2026
Celltrion Healthcare Netherlands B.V. €503,440
Pomalidomide
Cliniques universitaires Saint Luc · 19 May 2026
EG €268,870

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 848583-2025.